C4 Therapeutics, Inc. - Common Stock (CCCC)
3.5700
+0.00 (0.00%)
NASDAQ · Last Trade: Sep 16th, 5:09 AM EDT
A major recommendation change lit a big fire under the biotech as the trading week kicked off.
Via The Motley Fool · September 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 15, 2025
Via Benzinga · September 15, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 15, 2025

Via Benzinga · February 26, 2024
Via Benzinga · August 7, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · April 10, 2025

Via Benzinga · December 19, 2024

Via Benzinga · September 9, 2024

Via Benzinga · September 9, 2024

CCCC stock results show that C4 Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 1, 2024

CCCC stock results show that C4 Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.
Via Benzinga · February 20, 2024

These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns.
Via InvestorPlace · January 22, 2024

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days.
Via Benzinga · December 15, 2023

A look at five stocks that saw increased interest from Benzinga readers during the week.
Via Benzinga · December 15, 2023

Via Benzinga · December 15, 2023

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
Via Benzinga · December 13, 2023

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
Via Benzinga · December 13, 2023

Via Benzinga · December 13, 2023

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07.
Via Benzinga · December 13, 2023

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to 14,594.61. The S&P 500 also rose, gaining, 0.14% to 4,650.04.
Via Benzinga · December 13, 2023